Circulation. 2005;112:1580-1586
Published online before print September 6, 2005, doi: 10.1161/CIRCULATIONAHA.105.538272
Published online before print September 6, 2005, doi: 10.1161/CIRCULATIONAHA.105.538272
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;112:1580-1586.)
© 2005 American Heart Association, Inc.
Heart Failure |
Left Ventricular Reverse Remodeling but Not Clinical Improvement Predicts Long-Term Survival After Cardiac Resynchronization Therapy
From the Division of Cardiology (C.-M.Y., J.W.-H.F., Q.Z., Y.-S.C., S.-L.K.), Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong, and the Department of Cardiology (G.B.B., M.J.S., E.E.v.d.W., J.J.B.), Leiden University Medical Center, Leiden, the Netherlands.
Reprint requests to Prof Cheuk-Man Yu, Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, NT, Hong Kong. E-mail cmyu{at}cuhk.edu.hk
Received January 24, 2005; revision received June 16, 2005; accepted June 20, 2005.
Background— In patients with severe heart failure and dilated cardiomyopathy, cardiac resynchronization therapy (CRT) improves left ventricular (LV) systolic function associated with LV reverse remodeling and favorable 1-year survival. However, it is unknown whether LV reverse remodeling translates into a better long-term prognosis and what extent of reverse remodeling is clinically relevant, which were investigated in this study.
Methods and Results— Patients (n=141) with advanced heart failure (mean±SD age, 64±11 years; 73% men) who received CRT were followed up for a mean (±SD) of 695±491 days. The extent of reduction in LV end-systolic volume (LVESV) at 3 to 6 months relative to baseline was examined for its predictive value on long-term clinical outcome. The cutoff value for LV reverse remodeling in predicting mortality was derived from the receiver operating characteristic curve. Then the relation between potential predictors of mortality and heart failure hospitalizations were compared by Kaplan-Meier survival analysis, followed by Cox regression analysis. There were 22 (15.6%) deaths, mostly due to heart failure or sudden cardiac death. The receiver operating characteristic curve found that a reduction in LVESV of 
9.5% had a sensitivity of 70% and specificity of 70% in predicting all-cause mortality and of 87% and 69%, respectively, for cardiovascular mortality. With this cutoff value, there were 87 (61.7%) responders to reverse remodeling. In Kaplan-Meier survival analysis, responders had significantly lower all-cause morality (6.9% versus 30.6%, log-rank 
2=13.26, P=0.0003), cardiovascular mortality (2.3% versus 24.1%, log-rank 2=17.1, P<0.0001), and heart failure events (11.5% versus 33.3%, log-rank 2=8.71, P=0.0032) than nonresponders. In the Cox regression analysis model, the change in LVESV was the single most important predictor of all-cause (ß=1.048, 95% confidence interval=1.019 to 1.078, P=0.001) and cardiovascular (ß=1.072, 95% confidence interval=1.033 to 1.112, P<0.001) mortality. Clinical parameters were unable to predict any outcome event.
Conclusions— A reduction in LVESV of 10% signifies clinically relevant reverse remodeling, which is a strong predictor of lower long-term mortality and heart failure events. This study suggests that assessing volumetric changes after an intervention in patients with heart failure provides information predictive of natural history outcomes.
Key Words: pacing • prognosis • heart failure • echocardiography • mortality
This article has been cited by other articles:
 |
|
 |
|
  P. Lancellotti, M. Senechal, M. Moonen, E. Donal, J. Magne, E. Nellessen, E. Attena, B. Cosyns, P. Melon, and L. Pierard Myocardial contractile reserve during exercise predicts left ventricular reverse remodelling after cardiac resynchronization therapy Eur J Echocardiogr, July 1, 2009; 10(5): 663 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. J. Gademan, R. J. van Bommel, C. J. W. Borleffs, S. Man, J. C. W. Haest, M. J. Schalij, E. E. van der Wall, J. J. Bax, and C. A. Swenne Biventricular pacing-induced acute response in baroreflex sensitivity has predictive value for midterm response to cardiac resynchronization therapy Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H233 - H237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Bax and J. Gorcsan III Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective. J. Am. Coll. Cardiol., May 26, 2009; 53(21): 1933 - 1943. [Full Text] [PDF]
|
|
|
|
|
|
N. M. Hawkins, M. C. Petrie, M. I. Burgess, and J. J.V. McMurray Selecting patients for cardiac resynchronization therapy: the fallacy of echocardiographic dyssynchrony. J. Am. Coll. Cardiol., May 26, 2009; 53(21): 1944 - 1959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Parsai, B. Bijnens, G. R. Sutherland, A. Baltabaeva, P. Claus, M. Marciniak, V. Paul, M. Scheffer, E. Donal, G. Derumeaux, et al. Toward understanding response to cardiac resynchronization therapy: left ventricular dyssynchrony is only one of multiple mechanisms Eur. Heart J., April 2, 2009; 30(8): 940 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Parsai, A. Baltabaeva, L. Anderson, M. Chaparro, B. Bijnens, and G. R. Sutherland Low-dose dobutamine stress echo to quantify the degree of remodelling after cardiac resynchronization therapy Eur. Heart J., April 2, 2009; 30(8): 950 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Abraham, D. Kass, G. Tonti, G. F. Tomassoni, W. T. Abraham, J. J. Bax, and T. H. Marwick Imaging Cardiac Resynchronization Therapy J. Am. Coll. Cardiol. Img., April 1, 2009; 2(4): 486 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Funaro, G. La Torre, M. Madonna, L. Galiuto, A. Scara, A. Labbadia, E. Canali, A. Mattatelli, F. Fedele, F. Alessandrini, et al. Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study Eur. Heart J., March 1, 2009; 30(5): 566 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rivero-Ayerza and B. Schaer Device therapy in heart failure: do all treatment goals apply to all patients? Europace, March 1, 2009; 11(3): 280 - 282. [Full Text] [PDF]
|
|
|
|
|
|
N. Antonio, R. Teixeira, L. Coelho, C. Lourenco, P. Monteiro, M. Ventura, J. Cristovao, L. Elvas, L. Goncalves, and L. A. Providencia Identification of 'super-responders' to cardiac resynchronization therapy: the importance of symptom duration and left ventricular geometry Europace, March 1, 2009; 11(3): 343 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Landmesser, K. C. Wollert, and H. Drexler Potential novel pharmacological therapies for myocardial remodelling Cardiovasc Res, February 15, 2009; 81(3): 519 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ypenburg, R. J. van Bommel, C. J. W. Borleffs, G. B. Bleeker, E. Boersma, M. J. Schalij, and J. J. Bax Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J. Am. Coll. Cardiol., February 10, 2009; 53(6): 483 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q Zhang, J W-H Fung, J Y-S Chan, G Yip, Y-Y Lam, Y-J Liang, and C-M Yu Difference in long-term clinical outcome after cardiac resynchronisation therapy between ischaemic and non-ischaemic aetiologies of heart failure Heart, January 15, 2009; 95(2): 113 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Landolina, M. Gasparini, M. Lunati, M. Santini, R. Rordorf, A. Vincenti, P. Diotallevi, A. S. Montenero, C. Bonanno, T. De Santo, et al. Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome in patients with advanced heart failure Eur J Heart Fail, November 1, 2008; 10(11): 1073 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Umar, J. J. Bax, M. Klok, R. J. van Bommel, M. H.M. Hessel, B. den Adel, G. B. Bleeker, M. M. Henneman, D. E. Atsma, E. E. van der Wall, et al. Myocardial collagen metabolism in failing hearts before and during cardiac resynchronization therapy Eur J Heart Fail, September 1, 2008; 10(9): 878 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Kronborg, P. T. Mortensen, R. E. Kirkfeldt, and J. C. Nielsen Very long term follow-up of cardiac resynchronization therapy: Clinical outcome and predictors of mortality Eur J Heart Fail, August 1, 2008; 10(8): 796 - 801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S-A Chang, H-K Kim, H-Y Lee, S-Y Choi, B-K Koo, Y-J Kim, D-W Sohn, B-H Oh, Y-B Park, Y-S Choi, et al. Restoration of left ventricular synchronous contraction after acute myocardial infarction by stem cell therapy: new insights into the therapeutic implication of stem cell therapy for acute myocardial infarction Heart, August 1, 2008; 94(8): 995 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Gradaus, V Stuckenborg, A Loher, J Kobe, F Reinke, S Gunia, C Vahlhaus, G Breithardt, and C Bruch Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy Heart, August 1, 2008; 94(8): 1026 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Lim, G. Y.H. Lip, and J. E. Sanderson Ventricular optimization of biventricular pacing: a systematic review Europace, July 8, 2008; (2008) eun177v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. B. Popovic and J. D. Thomas In Search of a Holy Grail: Predicting Cardiac Resynchronization Therapy Outcomes by Echocardiography Circ Cardiovasc Imaging, July 1, 2008; 1(1): 3 - 5. [Full Text] [PDF]
|
|
|
|
|
|
C. Miyazaki, G. Lin, B. D. Powell, R. E. Espinosa, C. J. Bruce, F. A. Miller Jr, B. L. Karon, R. F. Rea, D. L. Hayes, and J. K. Oh Strain Dyssynchrony Index Correlates With Improvement in Left Ventricular Volume After Cardiac Resynchronization Therapy Better Than Tissue Velocity Dyssynchrony Indexes Circ Cardiovasc Imaging, July 1, 2008; 1(1): 14 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gasparini, A. Auricchio, M. Metra, F. Regoli, C. Fantoni, B. Lamp, A. Curnis, J. Vogt, C. Klersy, and for the Multicentre Longitudinal Observational Stu Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation Eur. Heart J., July 1, 2008; 29(13): 1644 - 1652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K Khadjooi, P W Foley, S Chalil, J Anthony, R E A Smith, M P Frenneaux, and F Leyva Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation Heart, July 1, 2008; 94(7): 879 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. O. Sweeney and F. W. Prinzen Ventricular Pump Function and Pacing: Physiological and Clinical Integration Circ Arrhythmia Electrophysiol, June 1, 2008; 1(2): 127 - 139. [Full Text] [PDF]
|
|
|
|
|
|
L. Di Biase, A. Auricchio, A. Sorgente, K. Civello, C. Klersy, F. Faletra, L. Riedlbauchova, D. Patel, M. Arruda, R. A. Schweikert, et al. The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy Eur. Heart J., May 30, 2008; (2008) ehn221v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vitarelli Echocardiographic selection of candidates for cardiac resynchronization therapy: the lack of evidence! Reply Eur J Echocardiogr, May 1, 2008; 9(3): 320 - 321. [Full Text] [PDF]
|
|
|
|
|
|
C. Leclercq, F. Gadler, W. Kranig, S. Ellery, D. Gras, A. Lazarus, J. Clementy, E. Boulogne, J.-C. Daubert, and for the TRIP-HF (Triple Resynchronization In Paced A Randomized Comparison of Triple-Site Versus Dual-Site Ventricular Stimulation in Patients With Congestive Heart Failure J. Am. Coll. Cardiol., April 15, 2008; 51(15): 1455 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J L Hare, C Jenkins, S Nakatani, A Ogawa, C-M Yu, and T H Marwick Feasibility and clinical decision-making with 3D echocardiography in routine practice Heart, April 1, 2008; 94(4): 440 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. W.L. De Boeck, M. Meine, G. E. Leenders, A. J. Teske, H. van Wessel, J. H. Kirkels, F. W. Prinzen, P. A. Doevendans, and M. J. Cramer Practical and conceptual limitations of tissue Doppler imaging to predict reverse remodelling in cardiac resynchronisation therapy Eur J Heart Fail, March 1, 2008; 10(3): 281 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Nagueh Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. J. Am. Coll. Cardiol., January 1, 2008; 51(1): 18 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. B Bleeker, C.-M. Yu, P. Nihoyannopoulos, J. de Sutter, N. Van de Veire, E. R Holman, M. J Schalij, E. E van der Wall, and J. J Bax Optimal use of echocardiography in cardiac resynchronisation therapy Heart, November 1, 2007; 93(11): 1339 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gorcsan III, M. Tanabe, G. B. Bleeker, M. S. Suffoletto, N. C. Thomas, S. Saba, L. F. Tops, M. J. Schalij, and J. J. Bax Combined Longitudinal and Radial Dyssynchrony Predicts Ventricular Response After Resynchronization Therapy J. Am. Coll. Cardiol., October 9, 2007; 50(15): 1476 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H.M. Hessel, G. B. Bleeker, J. J. Bax, M. M. Henneman, B. den Adel, M. Klok, M.J. Schalij, D. E. Atsma, and A. van der Laarse Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels Eur J Heart Fail, October 1, 2007; 9(10): 1058 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Europace, October 1, 2007; 9(10): 959 - 998. [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Kass Highlighting the R in CRT Circulation, September 25, 2007; 116(13): 1434 - 1436. [Full Text] [PDF]
|
|
|
|
|
|
G. B. Bleeker, S. A. Mollema, E. R. Holman, N. Van De Veire, C. Ypenburg, E. Boersma, E. E. van der Wall, M. J. Schalij, and J. J. Bax Left Ventricular Resynchronization Is Mandatory for Response to Cardiac Resynchronization Therapy: Analysis in Patients With Echocardiographic Evidence of Left Ventricular Dyssynchrony at Baseline Circulation, September 25, 2007; 116(13): 1440 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295. [Full Text] [PDF]
|
|
|
|
|
|
K. Vernooy, R. N.M. Cornelussen, X. A.A.M. Verbeek, W. Y.R. Vanagt, A. van Hunnik, M. Kuiper, T. Arts, H. J.G.M. Crijns, and F. W. Prinzen Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block hearts Eur. Heart J., September 1, 2007; 28(17): 2148 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Cabrera-Bueno, J. M. Garcia-Pinilla, J. Pena-Hernandez, M. Jimenez-Navarro, J. J. Gomez-Doblas, A. Barrera-Cordero, J. Alzueta-Rodriguez, and E. de Teresa-Galvan Repercussion of functional mitral regurgitation on reverse remodelling in cardiac resynchronization therapy Europace, September 1, 2007; 9(9): 757 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. Yu, F. Fang, Q. Zhang, G. W.K. Yip, C. M. Li, J. Y.-S. Chan, L. Wu, and J. W.-H. Fung Improvement of Atrial Function and Atrial Reverse Remodeling After Cardiac Resynchronization Therapy for Heart Failure J. Am. Coll. Cardiol., August 21, 2007; 50(8): 778 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Doughty, K. Poppe, and J. Stewart Predicting outcome in severe heart failure. Who will benefit from device therapy (CRT)? Eur. Heart J., August 1, 2007; 28(15): 1790 - 1792. [Full Text] [PDF]
|
|
|
|
|
|
J. N. Kirkpatrick, M. A. Vannan, J. Narula, and R. M. Lang Echocardiography in Heart Failure: Applications, Utility, and New Horizons J. Am. Coll. Cardiol., July 31, 2007; 50(5): 381 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chalil, B. Stegemann, S. Muhyaldeen, K. Khadjooi, R. E.A. Smith, P. J. Jordan, and F. Leyva Intraventricular Dyssynchrony Predicts Mortality and Morbidity After Cardiac Resynchronization Therapy: A Study Using Cardiovascular Magnetic Resonance Tissue Synchronization Imaging J. Am. Coll. Cardiol., July 17, 2007; 50(3): 243 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. McAlister, J. Ezekowitz, N. Hooton, B. Vandermeer, C. Spooner, D. M. Dryden, R. L. Page, M. A. Hlatky, and B. H. Rowe Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction: A Systematic Review JAMA, June 13, 2007; 297(22): 2502 - 2514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. Yu, J. E. Sanderson, T. H. Marwick, and J. K. Oh Tissue Doppler Imaging: A New Prognosticator for Cardiovascular Diseases J. Am. Coll. Cardiol., May 15, 2007; 49(19): 1903 - 1914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. B. Tournoux, C. Alabiad, D. Fan, A. A. Chen, M. Chaput, E. K. Heist, T. Mela, M. Mansour, V. Reddy, J. N. Ruskin, et al. Echocardiographic measures of acute haemodynamic response after cardiac resynchronization therapy predict long-term clinical outcome Eur. Heart J., May 1, 2007; 28(9): 1143 - 1148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W H Fung, J. Y S Chan, G. W K Yip, H. C K Chan, W. W L Chan, Q. Zhang, and C.-M. Yu Effect of left ventricular endocardial activation pattern on echocardiographic and clinical response to cardiac resynchronization therapy Heart, April 1, 2007; 93(4): 432 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C-M Yu, Q Zhang, Y-S Chan, C-K Chan, G W K Yip, L C C Kum, E B Wu, P-W Lee, Y-Y Lam, S Chan, et al. Tissue Doppler velocity is superior to displacement and strain mapping in predicting left ventricular reverse remodelling response after cardiac resynchronisation therapy Heart, October 1, 2006; 92(10): 1452 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gasparini, A. Auricchio, F. Regoli, C. Fantoni, M. Kawabata, P. Galimberti, D. Pini, C. Ceriotti, E. Gronda, C. Klersy, et al. Four-Year Efficacy of Cardiac Resynchronization Therapy on Exercise Tolerance and Disease Progression: The Importance of Performing Atrioventricular Junction Ablation in Patients With Atrial Fibrillation J. Am. Coll. Cardiol., August 15, 2006; 48(4): 734 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Zhang, J. W.-H. Fung, A. Auricchio, J. Y.-S. Chan, L. C.C. Kum, L. W. Wu, and C.-M. Yu Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure Eur. Heart J., June 2, 2006; 27(12): 1423 - 1430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Mannaerts Regression of left ventricular mass and wall thickness after cardiac resynchronization therapy: proof of pathophysiological concept Eur. Heart J., June 2, 2006; 27(12): 1392 - 1393. [Full Text] [PDF]
|
|
|
|
|
|
M. M. Scheinman and E. Keung The Year in Clinical Electrophysiology J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1207 - 1213. [Full Text] [PDF]
|
|
|
|
|
|
F. A Flachskampf and J.-U. Voigt Echocardiographic methods to select candidates for cardiac resynchronisation therapy. Heart, March 1, 2006; 92(3): 424 - 429. [Full Text] [PDF]
|
|
|
|
|
|
A. E. Weyman The Year in Echocardiography J. Am. Coll. Cardiol., February 21, 2006; 47(4): 856 - 863. [Full Text] [PDF]
|
|
|
|
|
|
W.H. W. Tang and G. S. Francis The Year in Heart Failure J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2125 - 2133. [Full Text] [PDF]
|
|